Skip to main content

Rare Mitochondrial DNA Mutation

Successful birth after preimplantation genetic testing for rare mitochondrial DNA mutation m.10197G>A


Here we report the first successful birth after preimplantation genetic testing for m.10197G>A mutation, a rare variant responsible for Leigh encephalopathy. Preimplantation genetic testing diagnosed the embryo with a mutant load of <5%, and transfer resulted in a live birth. The mutant load of embryos diagnosed in this case was skewed to the extremes. Skewed segregation patterns have been observed in common mutations, but this case suggests that the same phenomenon may be seen in this rare mutation.

Mitochondrial DNA (mtDNA) disorders are usually heteroplasmic, with cells harboring both wild-type and mutated mtDNA. They may become apparent once the number of affected mitochondria reaches a certain level. The threshold varies from tissue to tissue, and the percentage level of mutant mtDNA (mutant load, ML) also varies between and within individuals, making it difficult to establish a diagnosis. This is why there is no curative treatment currently available. A great deal of attention has been focused on the field of assisted reproductive technology, and preimplantation genetic testing (PGT) has emerged as an effective preventive option to identify embryos with MLs below disease-causing thresholds.

Not all mtDNA disorders are suitable for PGT, but studies on some of the common mtDNA mutations have shown a correlation between mtDNA heteroplasmy levels in the blastomeres and those in tissues throughout embryo–fetal development. Successful cases of PGT for these mutations, especially m.8993T>G mutation, have been reported to lead to the birth of a healthy baby.

The m.10197G>A mutation (NC_012920.1:m.10197G>A) is a rare pathogenic mutation of Leigh encephalopathy (LE). In a report of three different families with m.10197G>A, all affected children had severe LE with onset in infancy, with most dying within the first 1–2 years of life. Studies on Japanese patients with LE have reported the rarity of this variant in Japan and that LE in MT-ND3 gene is often severe. Here, we report the first successful PGT performed for the m.10197G>A mutation.

A 32-year-old female carrier of the m.10197G>A mutation in the MT-ND3 and her husband requested PGT to fulfill their desire for a healthy child. Their son (proband) was born at term following an uneventful pregnancy of healthy unrelated parents. From soon after birth, he had feeding difficulties and weight gain was poor. Psychomotor retardation became apparent by 4 months, and at 6 months of age, he was hospitalized for respiratory insufficiency. LE was suspected from these symptoms, and analysis of mtDNA mutation was carried out using peripheral blood. The results confirmed homoplasmy of a point mutation in the ND3 region, and a genetic diagnosis of LE was made. He died 7 months after birth owing to LE. The ML of the son and the mother was >99% and 11%, respectively. . After thorough genetic counseling for alternative methods of reproduction including PGT, informed consent was obtained. The study was approved by both ethical committees of the institute and Japan Society for Obstetrics and Gynecology.

gene mutation, point mutation, frameshift mutation, insertion, deletion, missense mutation, nonsense mutation, silent mutation, chromosomal mutation, genetic variation, somatic mutation, germline mutation, mutagenesis, DNA replication error, base pair substitution, genetic disorder, mutation hotspot, oncogene mutation, inherited mutation, spontaneous mutation,

#DNAmutation, #genetics, #molecularbiology, #mutations, #genetherapy, #genomeediting, #CRISPR, #DNAdamage, #genomicinstability, #hereditarydisease, #somaticmutation, #germlinemutation, #cancergenetics, #DNArepair, #pointmutation, #mutationresearch, #geneticvariation, #mutationtypes, #genemutation, #DNAchange


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...